Latest News for: guanylate cyclase

Edit

Chronic Kidney Disease Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 26 Mar 2025
It further highlights the inactive pipeline products in this space ... AstraZeneca ... Ziltivekimab ... BI 685509 is a novel small soluble guanylate cyclase (sGC) molecule activator that exhibits an in vitro profile consistent with that of an sGC activator ... City.
Edit

Best Methylene Blue Supplements in 2025 – Benefits, Dosage, & Where to Buy

Chico Enterprise Record 21 Mar 2025
Paid Advertisement ... With so many options, finding the right supplement can be overwhelming. That’s where we come in ... 1 ... Specifically, it can inhibit endothelial nitric oxide synthase (eNOS) and guanylate cyclase—two enzymes that affect vascular function.
  • 1
×